Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $512.1 million.

  • Qiagen's Total Current Liabilities fell 9508.52% to $512.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $512.1 million, marking a year-over-year decrease of 9508.52%. This contributed to the annual value of $512.1 million for FY2025, which is 9508.52% down from last year.
  • As of Q4 2025, Qiagen's Total Current Liabilities stood at $512.1 million, which was down 9508.52% from $973.4 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Total Current Liabilities ranged from a high of $10.4 billion in Q4 2024 and a low of $499.4 million during Q1 2021
  • Its 5-year average for Total Current Liabilities is $1.4 billion, with a median of $997.0 million in 2023.
  • As far as peak fluctuations go, Qiagen's Total Current Liabilities skyrocketed by 86547.56% in 2024, and later plummeted by 9508.52% in 2025.
  • Quarter analysis of 5 years shows Qiagen's Total Current Liabilities stood at $1.5 billion in 2021, then tumbled by 35.78% to $974.5 million in 2022, then grew by 10.75% to $1.1 billion in 2023, then soared by 865.48% to $10.4 billion in 2024, then crashed by 95.09% to $512.1 million in 2025.
  • Its last three reported values are $512.1 million in Q4 2025, $973.4 million for Q3 2025, and $1.1 billion during Q2 2025.